NCT00814125View on ClinicalTrials.gov

ATAC - Endometrial Sub-Protocol

PHASE3CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

June 30, 1997

Study Completion Date

December 31, 2005

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole (Arimidex)

1mg, orally, once daily

DRUG

Tamoxifen (Nolvadex)

20mg, orally, once daily

DRUG

Nolvadex placebo

DRUG

Arimidex placebo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY